Group 1 - The market sentiment around Hai Tian Wei Ye has been volatile, with initial enthusiasm leading to a significant drop in stock price on the listing day, falling below the issue price [1][2] - The recent trend in the market shows that the perception of risk-free arbitrage in IPOs has shifted, with a high probability of losses being observed in recent offerings [2][3] - The performance of other companies like Hengrui Medicine and CATL has created a misleading expectation of easy profits from IPOs, contributing to the current market dynamics [2][6] Group 2 - The recent market downturn has affected various sectors, including new consumption and innovative pharmaceuticals, indicating a broader sentiment shift [6] - The liquidity in the Hong Kong market remains high, as evidenced by the drop in overnight Hibor rates, yet this has not translated into positive market performance for many stocks [6] - The focus on stocks that are currently declining is emphasized, suggesting a strategy to concentrate on potential recovery opportunities rather than chasing new IPOs [4][6]
这阳光多明媚，而我在烂泥堆